BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Scilex Holding Company Announces Final Postponement of Annual Meeting of Stockholders

  Scilex Holding Company, a subsidiary of Sorrento Therapeutics, Inc., announced that the Company’s 2023 Annual Meeting of Stockholders that was scheduled to be held at 9:00 a.m. on Monday, April 17, 2023, has been postponed to Thursday, May 4, 2023 at 9:00 a.m..

  April 14, 2023

   · 

  7 min read
• Deals

  NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV

  NKGen Biotech, Inc. and Graf Acquisition Corp. IV announced that they have entered into a definitive agreement for a business combination.

  April 14, 2023

   · 

  17 min read
• Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update

  RELIEF THERAPEUTICS Holding SA reported its financial results for the full-year ended December 31, 2022 and provided a corporate update.

  April 14, 2023

   · 

  10 min read
• Hansa Biopharma to host conference call to provide interim results for January-March 2023 and a Business Update

  Hansa Biopharma AB will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023.

  April 14, 2023

   · 

  2 min read
• Business

  Zura Bio Announces Appointment of Chief Scientific Officer

  Zura Bio Limited, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, announced the appointment of Michael D. Howell, Ph.D., to the role of Chief Scientific Officer and Head of Translational Science.

  April 14, 2023

   · 

  7 min read
• QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023

  QIAGEN announced the launch of QIAseq Targeted cfDNA Ultra Panels that will enable researchers studying cancer and other diseases to turn cell-free DNA liquid-biopsy samples into libraries ready for next-generation sequencing in less than eight hours.

  April 14, 2023

   · 

  6 min read
• Business

  Immunis Appoints Neil Sahota as Chief Artificial Intelligence Officer

  Immunis, Inc., a private biotechnology company developing a novel treatment for age and disease-related immune decline, has appointed Neil Sahota as its Chief Artificial Intelligence Officer.

  April 14, 2023

   · 

  3 min read
• Lone Star Bio

  Caris Life Sciences to Showcase Research Highlighting the Clinical Value of Comprehensive Molecular Profiling at the American Association for Cancer Research Annual Meeting

  Caris Life Sciences® announced that the company and partners within the Caris Precision Oncology Alliance™ will collectively present four studies across 14 tumor types at the 2023 American Association for Cancer Research Annual Meeting being held April 14-19, 2023 in Orlando, Florida, at Booth Number 130.

  April 14, 2023

   · 

  5 min read
• Business

  Ginkgo Bioworks and the Government of the Democratic Republic of the Congo Announce Plans to Develop and Implement New Biosecurity Capabilities in the Region

  Ginkgo Bioworks and the Institut National de la Recherche Biomédicale today announced that they have entered into a Memorandum of Understanding (“MOU”) with the intent of developing and implementing new biosecurity capabilities in Democratic Republic of the Congo.

  April 14, 2023

   · 

  8 min read
• Genetown

  Bicycle Therapeutics to Present at the 2023 AACR Annual Meeting

  Bicycle Therapeutics plc today announced that the company will present four poster presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting, taking place in Orlando, FL on April 14-19, 2023.

  April 14, 2023

   · 

  2 min read